<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is common in hospitalized patients and is often accompanied by comorbidities; it is thus reasonable to ask whether the current standard treatments for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are suitable for in-hospital use </plain></SENT>
<SENT sid="1" pm="."><plain>We discuss the current <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering strategies and glycemic targets and derive practical recommendations for their application in hospitalized patients </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The pertinent literature, including clinical trials, review articles, guidelines, and manufacturers' information is selectively reviewed </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In <z:e sem="disease" ids="C0010340" disease_type="Disease or Syndrome" abbrv="">critically ill</z:e> patients with <z:mp ids='MP_0002055'>diabetes</z:mp>, the <z:chebi fb="105" ids="17234">glucose</z:chebi> concentration target value should be 140 to 180 mg/dL </plain></SENT>
<SENT sid="4" pm="."><plain>In stable patients, the target should be less than 140 mg/dL in the fasting state and less than 180 mg/dL after meals </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001988'>Hypoglycemic episodes</z:hpo> should be strictly avoided </plain></SENT>
<SENT sid="6" pm="."><plain>Temporary treatment with insulin is indicated for most hospitalized patients with <z:mp ids='MP_0002055'>diabetes</z:mp>, although oral <z:chebi fb="0" ids="35526">antidiabetic</z:chebi> agents may be continued if the hospitalization is expected to be brief </plain></SENT>
<SENT sid="7" pm="."><plain>Intravenous insulin is advisable in certain situations, e.g., long operations or metabolic decompensation </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi>-lowering strategies must be chosen individually for each patient, with consideration of the relevant comorbidities (e.g. <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e>, <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo>, <z:hpo ids='HP_0001394'>cirrhosis</z:hpo>, <z:hpo ids='HP_0000083'>renal failure</z:hpo>) and special conditions (e.g. prolonged fasting, administration of contrast agents, high-dose <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> treatment) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The treatment of patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in the hospital is very different from their treatment at home </plain></SENT>
<SENT sid="10" pm="."><plain>The particular conditions and comorbidities that can arise in the hospital necessitate flexible, individualized strategies for lowering blood <z:chebi fb="105" ids="17234">glucose</z:chebi> concentration </plain></SENT>
</text></document>